Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany
Working With Doctors To Test Against Virus
The antiviral specialist says MEK inhibitor could work against 2019-nCoV, but tests will take time.
You may also be interested in...
Codagenix, a company backed by Novartis, Merck and the Bill & Melinda Gates Foundation, has tied up with India’s Serum Institute to develop a vaccine against SARS-CoV-2, joining a heated race against the dreaded COVID-19 outbreak.
Many clinicians doubt that aducanumab can really help slow the decline in Alzheimer’s patients – but US FDA could offer it the benefit of the doubt.
Timing means full EU approval could coincide with US FDA authorization later this year.